close 74% of retail investor accounts lose money when trading CFDs with this provider. Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
SearchSearch
Change languageEnglish (International)
Dashboard

MDT

85.95

-0.19%↓

A

114.73

+0.89%↑

VEEV

173.19

-1.33%↓

HQY

83.42

+0.58%↑

PHR.US

8.49

+5.47%↑

MDT

85.95

-0.19%↓

A

114.73

+0.89%↑

VEEV

173.19

-1.33%↓

HQY

83.42

+0.58%↑

PHR.US

8.49

+5.47%↑

MDT

85.95

-0.19%↓

A

114.73

+0.89%↑

VEEV

173.19

-1.33%↓

HQY

83.42

+0.58%↑

PHR.US

8.49

+5.47%↑

MDT

85.95

-0.19%↓

A

114.73

+0.89%↑

VEEV

173.19

-1.33%↓

HQY

83.42

+0.58%↑

PHR.US

8.49

+5.47%↑

MDT

85.95

-0.19%↓

A

114.73

+0.89%↑

VEEV

173.19

-1.33%↓

HQY

83.42

+0.58%↑

PHR.US

8.49

+5.47%↑

Home・Stock List・Co-Diagnostics Inc
Search

Co-Diagnostics Inc

Open

SectorHealthcare

1.62 -11.48

Neutral

Price update 1 Apr 2026, 17:57 UTC

BuySell

Overview

Share price change

24h

Current

Min

1.52

Max

1.88

Key metrics

By Trading Economics

Income

1.8M

-5.9M

Sales

-18K

145K

Profit margin

-4,049.266

Employees

132

EBITDA

1M

-6.7M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+194.12% upside

Dividends

By Dow Jones

Next Earnings

7 May 2026

Market Stats

By TradingEconomics

Market Cap

4.8M

Previous open

13.1

Previous close

1.62

News Sentiment

By Acuity

100%

0%

330 / 349 Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

0.3495 / 0.3699 Support & Resistance

Co-Diagnostics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

31 Mar 2026, 23:31 UTC

Hot Stocks

Stocks to Watch: Nike, RH, NCino

DJ

Read

31 Mar 2026, 22:35 UTC

Earnings

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

DJ

Read

1 Apr 2026, 00:00 UTC

Acquisitions, Mergers, Takeovers

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

DJ

Read

31 Mar 2026, 23:50 UTC

Acquisitions, Mergers, Takeovers

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

DJ

Read

31 Mar 2026, 23:43 UTC

Market Talk

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

DJ

Read

31 Mar 2026, 23:33 UTC

Market Talk
Major News Events

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

DJ

Read

31 Mar 2026, 23:21 UTC

Earnings

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

DJ

Read

31 Mar 2026, 23:14 UTC

Market Talk
Earnings

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

DJ

Read

31 Mar 2026, 23:12 UTC

Market Talk

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

DJ

Read

31 Mar 2026, 22:36 UTC

Earnings

China Vanke 2025 Loss Widens >000002.SZ

DJ

Read

31 Mar 2026, 22:36 UTC

Earnings

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

DJ

Read

31 Mar 2026, 22:36 UTC

Earnings

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

DJ

Read

31 Mar 2026, 22:36 UTC

Earnings

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

DJ

Read

31 Mar 2026, 22:36 UTC

Earnings

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

DJ

Read

31 Mar 2026, 21:46 UTC

Acquisitions, Mergers, Takeovers

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

DJ

Read

31 Mar 2026, 21:36 UTC

Market Talk

West African Resources's Costs Higher Than Bull Expected -- Market Talk

DJ

Read

31 Mar 2026, 21:35 UTC

Earnings

Nike Expects China Sales Down 20% in 4Q, CFO Says

DJ

Read

31 Mar 2026, 21:35 UTC

Earnings

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

DJ

Read

31 Mar 2026, 21:35 UTC

Earnings

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

DJ

Read

31 Mar 2026, 21:33 UTC

Acquisitions, Mergers, Takeovers

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

DJ

Read

31 Mar 2026, 21:33 UTC

Earnings

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

DJ

Read

31 Mar 2026, 21:32 UTC

Earnings

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

DJ

Read

31 Mar 2026, 21:28 UTC

Earnings

Nike Expects to End 4Q With Elevated Inventory, CFO Says

DJ

Read

31 Mar 2026, 21:26 UTC

Earnings

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

DJ

Read

31 Mar 2026, 21:25 UTC

Earnings

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

DJ

Read

31 Mar 2026, 21:24 UTC

Market Talk
Earnings

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

DJ

Read

31 Mar 2026, 21:22 UTC

Earnings

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

DJ

Read

31 Mar 2026, 21:22 UTC

Earnings

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

DJ

Read

31 Mar 2026, 21:21 UTC

Earnings

Nike's Digital Channel Still Too Promotional, CFO Says

DJ

Read

31 Mar 2026, 21:20 UTC

Earnings

Nike CEO: Converse Remains Important to Portfolio

DJ

Read

Peer Comparison

Price change

Co-Diagnostics Inc Forecast

Price Target

By TipRanks

194.12% upside

12 Months Forecast

Average 5 USD  194.12%

High 5 USD

Low 5 USD

Based on 1 Wall Street analysts offering 12 month price targets forCo-Diagnostics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

1 ratings

0

Buy

1

Hold

0

Sell

Based on 1 analysts giving stock ratings to Co-Diagnostics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

0.3495 / 0.3699Support & Resistance

Short Term

Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Weak Bearish Evidence

There is one bearish event.

Long Term

No Evidence

There are no events.

Sentiment

By Acuity

330 / 349 Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

MDT

Medtronic PLC

85.95

↓-0.19%

A

Agilent Technologies Inc

114.73

↑ +0.89%

VEEV

Veeva Systems Inc

173.19

↓-1.33%

HQY

HealthEquity Inc

83.42

↑ +0.58%

PHR.US

Phreesia Inc

8.49

↑ +5.47%
help-icon Live chat